BSEInsider Trading / SAST1h ago · 23 Oct 2026, 10:08 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd

Biogen Pharmachem Industries Ltd · 531752

✦ AI SummaryRelated Party

Biogen Pharmachem Industries Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Rama Shiva Lease Finance Private Limited, indicating a change in shareholding in the company.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

CC7DF2A3_5081_4227_8913_90596006FF6B_100818.pdf

pdf

Download →
View document text
RAMA SHIVA LEASE FINANCE PRIVATE LIMITED CIN: U65910GJ1995PTC024753 Reg. Office Address: 24 LAXMI CHAMBERS, NAVJIVAN PRESS ROAD OPP OLD GUJARAT HIGH COURT AHMEDABAD - 380014 Through E-Mail Date: 22.10.2026 Department of Corporate Services, BSE Limited P. J. Towers, Dalal Street, Mumbai- 400001 Dear Sir, Sub: Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Ref: Scrip Code: 531752 Scrip ID: BIOGEN We are sending herewith Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Please find above in order and acknowledge the same. Thanking You. Yours faithfully, For, Rama Shiva Lease Finance Private Limited RAMASHIVA @H FINANCE (P.) LTD. “AGEROFESEigHH: c.C. Compliance Officer Biogen Pharmachem Industries Limited Shop No. 8, First Floor, Makers - 1 Building, Jawahar Road, Rajkot-360001 E mail: suntechnooverseas@gmail.com Format for Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 | Name of the Target Company (TC) Biogen Pharmachems Industries Limited (BSE Security Code: 531752) 2 | Name(s) of the aequirer/Seller and RAMA SHIVA LEASE FINANCE PRIVATE LIMITED Persons Acting in Concert (PAC) with the acquirer 3 | Whether the acquirer belongs No to Promoter/Promoter group 4 | Name(s) of the Stock Exchange(s) BSE Limited where the shares of TC are Listed 5 | Details of the acquisition/ Number % w.rt. total % w.rt total diluted disposal/holding of shares/voting share/voting share/voting capital of the rights/holding of the Acquirer capital Tc(*) wherever and PAC applicable Before the aequisition/disposal under consideration, holding of: a) Shares carrying voting rights 4,25,83,333 4.04 4.04 b) Shares in the nature of 00 00 00 encumbrance (pledge/ lien/ non- disposal undertaking/ others) 00 00 c) Voting rights (VR) otherwise than by shares d) Warrants/convertible 00 00 securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) 4,25,83,333 4.04 4.04 Total (a+b+c) Details of acquisition/sale a) Shares carrying voting rights 4,25,83,333 4.04 4.04 acquired/sold 00 00 b) VRs acquired /sold otherwise than by shares c)Warrants/convertible 00 00 00 securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares in the nature of encumbrance (pledge/ lien/ non- disposal undertaking/ others) 4,25,83,333 4.04 4.04 Total (a+b+c) RAMASHIVA LEASE WANCE (P LTD- After the-acquisition/sale, holding of: a) Shares carrying voting rights 00 00 00 b) VRs otherwise than by shares 00 00 00 c) Warrants/convertible securities/any other 00 00 00 instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition. d) Shares in the nature of encumbrance 00 00 00 (pledge/ lien/ non-disposal undertaking/ others) Total (a+b+c) 00 00 00 6 | Mode of acquisition / sale (e.g. open market / off-market / public issue / rights issue / | Open Market preferential allotment / inter-se transfer etc). 7 | Date of acquisition / sale of shares / VR or | 16.10.2026 date of receipt of intimation of allotment of shares, whichever is applicable 8 | Equity share capital / total voting capital | Rs.1,05,30,36,833 /- divided in to 1053036833 of the TC before the said acquisition / sale | Equity share of Rs. 1/- each. 9 | Equity share capital/ total voting capital | Rs.1,05,30,36,833 divided in to 1053036833 of the TC after the said acquisition / sale | Equity share of Rs. 1/- each. 10 | Total diluted share/voting capital of the TC | Rs.1,05,30,36,833 /- divided in to 1053036833 after the said acquisition/sale. Equity share of Rs. 1/- each. (*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. SEFINANCE PRIVATE LIMITED